2018 global prescription drug sales fall against Q4 forecasts

At 8%, Novartis recorded the second largest decrease out of the top 20 pharmaceutical companies.



  • Prescription drug sales global 2018
  • Prescription drug sales global 2018
  • Prescription drug sales global 2018